Tianda Pharmaceuticals Limited
Research Tianda Pharmaceuticals Limited (0455.HK) on Bullrun: market cap HKD 236.50M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0455.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 236.50M
- Financial periodFY2025
- RevenueHKD 322.95M
- Revenue growth-2.1%
- Net income-HKD 70.00M
- Free cash flow-HKD 6.58M
- Gross margin41.3%
Valuation Snapshot
latest market cap is HKD 236.50M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | HKD 322.95M | -HKD 70.00M | -HKD 6.58M | 41.3% | n/a | HKD 64.81M | HKD 132.66M | HKD 456.64M |
| FY2024 | HKD 329.94M | -HKD 61.37M | -HKD 52.30M | 46.1% | -0.03 | HKD 85.69M | HKD 127.45M | HKD 505.84M |
| FY2023 | HKD 532.09M | -HKD 24.16M | -HKD 116.04M | 48.0% | -0.01 | HKD 162.44M | HKD 113.60M | HKD 592.07M |
| FY2022 | HKD 509.96M | -HKD 19.77M | -HKD 54.68M | 47.3% | -0.01 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 236.50M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
| Year | Dividends/share |
|---|---|
| FY2024 | 0 HKD |
| FY2023 | 0 HKD |
| FY2022 | 0.01 HKD |
About Tianda Pharmaceuticals Limited
Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. It operates through the Chinese Medicine; Pharmaceuticals and Medical Technologies; and Medical and Healthcare Services segments. The company offers Chinese herbal medicine, Chinese medicine decoction pieces, Chinese medicine products, and Chinese medicine clinical services.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Tianda Pharmaceuticals Limited's market cap?
Tianda Pharmaceuticals Limited's market capitalization is HKD 236.50M.
What does Tianda Pharmaceuticals Limited do?
Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. It operates through the Chinese Medicine; Pharmaceuticals and Medical Technologies; and Medical and Healthcare Services segments. The company offers Chinese herbal medicine, Chinese medicine decoction pieces, Chinese medicine products, and Chinese medicine clinical services.